Hergen Spits

Dr Spits is (now emeritus-) professor of Cell Biology at the Amsterdam University Medical Centers from 2002. Prior to that Spits was at the Netherlands Cancer Institute in Amsterdam where he was a senior staff scientist and served as Head of the Immunology Department. Spits earned his PhD degree at the University of Amsterdam and conducted research at the Dana Farber Institute for Cancer Research, Harvard University in Boston.

Spits also worked in industry. He served as a Senior Director Immunology Research at Genentech. He also held several positions at Schering Plough, first at the Schering –Plough Institute for Immunological Research in Lyon and then at the DNAX Research Institute for Molecular Biological Research in Palo Alto in California. He is a founder of AIMM Therapeutics that develops monoclonal antibodies for treatment of diseases with a high unmet medical need and was its CSO till 2019.